Australia Medical Oxygen Concentrator Market is Booming: Expected to Reach USD 92.7 Million in 2027

Published | 28 April 2021

A study recently conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Australia Medical Oxygen Concentrator market was worth USD 49.4 million in 2020. The market is projected to reach USD 92.7 million by 2027 with a (CAGR) of 11.3% the growing incidence of chronic obstructive pulmonary diseases (COPD) in Australia. Chronic Obstructive Pulmonary Disease (COPD) is a collective term for a group of progressive lung conditions including emphysema, chronic bronchitis, and chronic asthma. COPD narrows the bronchial passages, making breathing difficult. It is a chronic disease with no known cure. COPD wreaks havoc on the lungs by permanently damaging the airways and airway sacs (alveoli)..

The growth of Australia Medical Oxygen Concentrator Market can be attributed to the main cause of COPD is said to be inflammation, oxidative stress, and an imbalance ofproteases (enzymes that break up specific proteins) and anti-proteases in the lung. Oxidative stress is generally caused by oxidative chemicals and highly reactive free radicals present in tobacco. Generally, all smokers suffer from lung inflammation but not all develop COPD. People suffering from deficiency of alpha-1 antitrypsin and a rare inherited condition called cutis laxa are at a greater risk of developing COPDs.

Though COPD is incurable, various treatments and processes can help in decelerating the spread of the condition and controlling the symptoms. Another therapeutic option for managing the spread of the disease is oxygen therapy, which has both short and long-term benefits. People with COPD may either use oxygen tanks or medical oxygen concentrators to meet their extra oxygen needs.


Increasing Technological Advancements for the Miniaturization of the Oxygen Concentrators

Over the years, the use of pneumatics has helped greatly in reducing the size of the oxygen concentrators. There are no strict regulations for the designing of pneumatic components to be used in medical oxygen concentrators, which allows companies to be innovative with the design of pneumatic components. Pneumatic components were originally designed for industrial use, but as demand for them from the medical industry for use in medical oxygen concentrators grew, companies had to adapt. Pneumatic companies and medical device manufacturers have formed partnerships over the years for the development of miniaturization of medical devices and development of other advanced devices. Medical device manufacturers often use zeolites and nano-size zeolites to remove nitrogen from the air, which enables medical oxygen concentrators to be smaller. Reduction in the size of batteries, integration of nanotechnology, reduction in the size of medical oxygen concentrator absorber has all contributed to reducing the size of medical oxygen concentrators.


 Low acceptance of medical oxygen concentrators

Oxygen therapy is gaining increasing acceptance in Australia but penetration of medical oxygen concentrators is very low. Patients prefer using portable oxygen cylinders due to the high maintenance costs of oxygen concentrators. As a result, oxygen concentrators compete directly with oxygen cylinders for market share and customer base. Oxygen cylinders are widely available and contain extremely pure oxygen. Additionally, oxygen cylinders also have low maintenance, require no electricity, and are quite reliable.

On the other hand, oxygen concentrators require power to operate. Stationary medical oxygen concentrators use electricity, while portable medical oxygen concentrators use batteries to transform oxygen from the air into concentrated oxygen. In case of mechanical failure in the medical oxygen cylinder or no availability of electricity, backup oxygen cylinders are necessary.

When a high flow rate of oxygen is required, the purity of oxygen suffers in medical oxygen concentrators. Apart from these factors, the requirement of regular maintenance, heat, noise, and vibration production are other associated issues with medical oxygen concentrators. Portable medical oxygen concentrators alleviate some of these problems, but they are very expensive. Also, portable medical oxygen cylinders are suitable for people with low oxygen requirements and are not suitable when continuous oxygen flow is required. Many businesses are trying to find a solution to the problems with medical oxygen concentrations described above as these issues are acting as a restraint for the growth of the medical oxygen concentrators market in Australia.

The Portable Oxygen Concentrator segment is the largest based on the product type

The portable oxygen concentrator segment accounted for the largest share in 2020 with 67.95% in the equipment market and 63.29% in the rental market. This segment is likely to dominate the market during the forecast period. This growth can be attributed to the benefits offered by the portable oxygen concentrator as they are easy to use, and even old age people can take this equipment along with them and use it effectively. The increasing number of respiratory-related diseases such as COPD, and lung-related diseases further drives the market growth for portable oxygen concentrators both in equipment and rental markets.

Australia Medical Oxygen Concentrator Market: Regional Insights

Based on region Australia medical oxygen concentrators equipment market is segmented into New South Wales, Queensland, South Australia, Tasmania, Victoria, Western Australia, Australian Capital, and The Northern Territory. New South Wales accounted for the largest share in the market. This growth can be attributed to the increasing expenditure in the medical and healthcare sector by the governments. In addition, the increasing number of privately owned hospitals and clinics in this region drives the growth of the Australia medical oxygen equipment market.

Impact of COVID-19 Outbreak

The COVID-19 pandemic has raised major obstacles for global supply chains. Multiple national lockdowns continue to hinder or even halt the movement of raw materials and finished products, disrupting manufacturing. As a result, many organizations have suffered staff shortages and losses due to COVID-19. The COVID-19-induced pandemic has affected supply chains across all the industries all over the world. Supply chains are increasingly vulnerable to disruption as the world experiences more regular crises, making supply chain resilience an even greater necessity for Australian businesses. Many industries in Australia depend on a globalized supply chain to meet the demands of end consumers while remaining cost-effective. Australian businesses, in particular, routinely seek international sources of supply for parts and manufactured goods.

Australia closed its international border in March 2020, making it impossible for many manufacturers to ship goods from overseas. Because of the pandemic, the demand for medical oxygen concentrators was high, and the supply chain was disrupted, increasing the overall price of medical oxygen concentrators. The COVID-19 also highlighted supply chain errors and how, with the aid of digitalization, these errors can be corrected, making the supply chain more efficient and streamlined.

Key Market Players in the medical oxygen concentrators market are Philips Respironics, Invacare Corporation, Drive Devilbliss Healthcare, Inogen, Inc., Caire Inc., Nidek Medical Products, Inc, Sysmed (china) Co., Ltd.and other prominent players.

Don't miss the business opportunity of Australia Medical Oxygen Concentrator Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Australia medical oxygen concentrator market size & forecast. The report promises to provide recent technology trends of the Australia medical oxygen concentrator market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges and competitive dynamics of the market.


About Us

BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer all-inclusive market research reports by analysing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.